Back to search

University of Leeds

Engineering cholera toxin for the targeted delivery of oligonucleotides

Abstract

dc:description.abstract

Half of the 20 best-selling prescription drugs of 2014 were large biologic therapeutics, however to date there have only been two licensed non-aptamer oligonucleotide drugs. Oligonucleotides have proven highly successful at modification of gene expression in the laboratory, but the lack of a robust delivery vehicle has largely prevented their transferal to clinical use. That role could be filled by cholera toxin, a protein produced by Vibrio cholerae, responsible for the diarrhoeal symptoms of cholera infection. Cholera toxin targets cells presenting GM1 ganglioside on their surface for endocytosis and carries a toxic payload to the endoplasmic reticulum (ER) by retrograde translocation. Several non-toxic variants of cholera toxin have been produced which are capable of carrying a cargo into cells, but to date it has not been tested for oligonucleotide delivery. The non-toxic subunit of cholera toxin responsible for endocytosis, CTB, was expressed in the absence of the toxic A subunit. CTB was site-specifically labelled with fluorescein using sortase A and shown to carry the payload into Vero cells. The endocytic pathway was able to be altered through modification of the protein sequence. Subsequently, a short RNA duplex was delivered to different locations in Vero cells by two subtly different CTB variants. Several strategies were then trialled to promote oligonucleotide release from CTB and export to the cytosol. While oligonucleotides conjugated via a disulfide bond were released in the ER, and a short hydrophobic peptide mediated export of an oligonucleotide-CTB complex from the ER, a combination of both was not observed. This study showed CTB has the potential to function as an effective delivery vehicle for therapeutic oligonucleotides, but also that there remains work to do and are hurdles to overcome to achieve this goal. It provides a platform for the development of CTB, or other similar proteins, for clinical use.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2016

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Machin, Darren Christopher
Advisors dc:contributor.advisor
  • Webb, Michael E
  • Turnbull, W Bruce
  • Macdonald, Andrew
  • Andrews, Benjamin I
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.707042

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Machin, Darren Christopher. Engineering cholera toxin for the targeted delivery of oligonucleotides. doctoral thesis, University of Leeds, 2016.